Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cytek Biosciences, Inc. CTKB
$7.58
-$0.51 (-6.71%)
На 18:04, 12 мая 2023
+111.08%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
1581853807.00000000
-
week52high
16.05
-
week52low
7.38
-
Revenue
164036000
-
P/E TTM
687
-
Beta
0.00000000
-
EPS
0.02000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 18 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 12 авг 2022 г. |
| Goldman Sachs | Buy | Buy | 11 авг 2022 г. |
| Goldman Sachs | Buy | Buy | 14 июл 2022 г. |
| Piper Sandler | Overweight | Overweight | 16 мая 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Jeanmonod Patrik | D | 76132 | 3500 | 24 янв 2023 г. |
| Yan Ming | D | 7946833 | 20000 | 19 янв 2023 г. |
| Jiang Wenbin | D | 7740314 | 20000 | 09 янв 2023 г. |
| Jeanmonod Patrik | D | 79632 | 3500 | 27 дек 2022 г. |
| Yan Ming | D | 7966833 | 20000 | 19 дек 2022 г. |
| Jiang Wenbin | D | 7760314 | 20000 | 07 дек 2022 г. |
| Jiang Wenbin | D | 7780314 | 10000 | 29 ноя 2022 г. |
| Ball Jack | D | 0 | 13333 | 29 ноя 2022 г. |
| Ball Jack | A | 26999 | 13333 | 29 ноя 2022 г. |
| Ball Jack | A | 13666 | 10666 | 29 ноя 2022 г. |
Новостная лента
Cytek Biosciences to Participate in Upcoming Investor Conferences
GlobeNewsWire
06 февр 2023 г. в 16:05
FREMONT, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the following investor conferences:
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More - Corcept Therapeutics (NASDAQ:CORT), Cytek Biosciences (NASDAQ:CTKB)
Benzinga
15 дек 2022 г. в 07:19
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Cytek Biosciences, Inc. (CTKB) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 16:45
Cytek Biosciences, Inc. (NASDAQ:CTKB ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Paul Goodson - Head, IR Wenbin Jiang - President, CEO and Chairman Patrik Jeanmonod - CFO Conference Call Participants Tejas Savant - Morgan Stanley Matthew Sykes - Goldman Sachs David Westenberg - Piper Sandler Operator Welcome to Cytek's Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
GlobeNewsWire
26 окт 2022 г. в 16:05
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2022 after market close on Wednesday, November 9th, 2022. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
GlobeNewsWire
30 авг 2022 г. в 16:05
FREMONT, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 20th Annual Morgan Stanley Global Healthcare Conference in New York, NY.